| Homology and enzymatic requirements of microhomology-dependent alternative end joining S Sharma, SM Javadekar, M Pandey, M Srivastava, R Kumari, ... Cell death & disease 6 (3), e1697-e1697, 2015 | 197 | 2015 |
| Unleashing a novel function of Endonuclease G in mitochondrial genome instability S Dahal, H Siddiqua, S Sharma, RK Babu, D Rathore, S Sharma, ... Elife 11, e69916, 2022 | 15 | 2022 |
| Acute toxicity analysis of Disarib, an inhibitor of BCL2 S Sharma, KK Varsha, S Kumari, V Gopalakrishnan, AE Jose, ... Scientific reports 10 (1), 15188, 2020 | 15 | 2020 |
| Fermentation of starch to ethanol by an amylolytic yeast Saccharomyces diastaticus SM-10 S Sharma, M Pandey, B Saharan NISCAIR-CSIR, India, 2002 | 13 | 2002 |
| SCR7, an inhibitor of NHEJ can sensitize tumor cells to ionization radiation V Gopalakrishnan, S Sharma, U Ray, M Manjunath, D Lakshmanan, ... Molecular Carcinogenesis 60 (9), 627-643, 2021 | 11 | 2021 |
| Characterization of DNA double‐strand break repair pathways in diffuse large B cell lymphoma V Gopalakrishnan, S Dahal, G Radha, S Sharma, SC Raghavan, ... Molecular Carcinogenesis 58 (2), 219-233, 2019 | 11 | 2019 |
| Evaluation of potential role of R-loop and G-quadruplex DNA in the fragility of c-MYC during chromosomal translocation associated with Burkitt’s lymphoma N Kumari, K Das, S Sharma, S Dahal, SS Desai, U Roy, A Sharma, ... Journal of Biological Chemistry 299 (12), 2023 | 6 | 2023 |
| Identification and characterization of mercaptopyrimidine‐based small molecules as inhibitors of nonhomologous DNA end joining U Ray, VK Gopinatha, S Sharma, L Goyary, B Choudhary, K Mantelingu, ... The FEBS Journal 290 (3), 796-820, 2023 | 6 | 2023 |
| Delineating the mechanism of fragility at BCL6 breakpoint region associated with translocations in diffuse large B cell lymphoma V Gopalakrishnan, U Roy, S Srivastava, KM Kariya, S Sharma, ... Cellular and Molecular Life Sciences 81 (1), 21, 2024 | 4 | 2024 |
| G4 DNA present at human telomeric DNA contributes toward reduced sensitivity to γ-radiation induced oxidative damage, but not bulky adduct formation U Ray, S Sharma, I Kapoor, S Kumari, V Gopalakrishnan, SV Vartak, ... International Journal of Radiation Biology 97 (9), 1166-1180, 2021 | 4 | 2021 |
| Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats S Sharma, KK Varsha, U Ray, H Siddiqua, AE Jose, S Muninarasimaiah, ... Scientific reports 11 (1), 9982, 2021 | 4 | 2021 |
| Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated … M Manjunath, F Ravindran, S Sharma, H Siddiqua, SC Raghavan, ... International Journal of Molecular Sciences 25 (12), 6485, 2024 | 3 | 2024 |
| Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential R Joy, H Siddiqua, S Sharma, M Raveendran, F John, PA Hassan, ... ACS omega 8 (43), 40729-40740, 2023 | 2 | 2023 |
| Nanotechnology in Defence and Security BP Choudhary, B Kumar, S Sharma, AK Sharma, R Karmakar, NB Singh Emerging Applications of Nanomaterials 141, 151-168, 2023 | 2 | 2023 |
| Novel synthetic aromatic thiourea derivatives and investigations on their cytotoxic potential efficacy U Ray, F John, S Pooppadi, J George, S Sharma, SC Raghavan Journal of Heterocyclic Chemistry 58 (1), 40-47, 2021 | 2 | 2021 |
| A Coumarin–Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins S Nirgude, MV Shahana, F Ravindran, S Kumar, S Sharma, R Mahadeva, ... Molecules 28 (13), 5226, 2023 | 1 | 2023 |
| Mutations at BCL11B Exon 4 Associated with T Cell Acute Lymphoblastic Leukemia Are Facilitated by AID and Formation of Non-B DNA Conformations U Roy, A Sharma, S Sharma, S Dahal, N Kumari, SS Desai, S Kumari, ... Molecular and Cellular Biology 44 (12), 590-606, 2024 | | 2024 |
| A novel approach toward the multigram synthesis of a novel Bcl2-specific inhibitor, and evaluation of its biological activity M Raveendran, S Sharma, SS Palimkar, ML Kumar, H Sahana, ... European Journal of Medicinal Chemistry Reports 11, 100157, 2024 | | 2024 |
| PP053 SP11, a promising coumarin-imidazothiadiazole derivative, targets HSP90 and client proteins to inhibit tumor growth MV Shahana, S Nirgude, F Ravindran, S Kumar, S Sharma, R Mahadeva, ... ESMO Open 8 (1), 2023 | | 2023 |
| Curcumin derivative 1, 2-bis ((3E, 5E)-3, 5-bis (4-chlorobenzylidene)-4-oxopiperidine-1-yl) ethane-1, 2-dione hemihydrate, ST09, regulates miR-197-5p/GPX3 axis in breast cancer … S Nirgude, S Desai, F Ravindran, R Mahadeva, S Sharma, J Thumsi, ... | | 2022 |
